Inovio Pharmaceuticals (INO) PT Lowered to $7 at Piper Sandler
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $8.72 -0.91%
Rating Summary:
9 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 42
Rating Summary:
9 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 42
Trade Now!
Join SI Premium – FREE
Piper Sandler analyst Christopher Raymond lowered the price target on Inovio Pharmaceuticals (NASDAQ: INO) to $7.00 (from $8.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Banca Mediolanum SpA (BMED:IM) PT Raised to EUR9.70 at Goldman Sachs
- flatexDEGIRO AG (FTKn:GR) (FNNTF) PT Raised to EUR100 at Goldman Sachs
- Roots Corp. (ROOT:CN) (RROTF) PT Raised to Cdn$4 at Scotiabank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
